Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Dishan H, Gunawardana"'
Autor:
Meir Lichtenstein, David A. Pattison, Dishan H. Gunawardana, James Westcott, Nathan Better, Dinesh Sivaratnam, H. B. Toh, Simon Forehan
Publikováno v:
Nuclear Medicine Communications. 36:356-362
Amiodarone-induced thyrotoxicosis (AIT) is caused by excessive hormone synthesis and release (AIT I), a destructive thyroiditis (AIT II), or a combination of both (AIT Ind). Although no gold-standard diagnostic test is available, technetium-99m sesta
Autor:
Sylvia J. Gong, Dishan H. Gunawardana, Andrew M. Scott, John I. Sachinidis, Hui K Gan, Graeme O'Keefe, Daryl Lim Joon, Joe Chang, Morikatsu Wada, Vincent Khoo, Sze Ting Lee, N. Anderson
Publikováno v:
Acta Oncologica. 52:1723-1729
This study investigates the use of (18)F-fluoromisonidazole (FMISO) PET-guided radiotherapy dose painting for potentially overcoming the radioresistant effects of hypoxia in head and neck squamous cell carcinoma (HNSCC).The study cohort consisted of
Autor:
Jayne Ramshaw, Rodney J. Hicks, Peter Robins, Dishan H. Gunawardana, Ian D. Kirkwood, Joseph C.H. Wong, Andrew M. Scott, Ivan Ho Shon
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. 36:347-353
Positron emission tomography (PET) was evaluated in low-grade non-Hodgkin lymphoma (NHL) to determine its impact on staging and management and to compare PET and gallium scans.PET resulted in management plan changes in 74 patients with untreated low-
Publikováno v:
Journal of Nuclear Medicine. 49:1593-1600
The primary aim of this study was to determine the impact of PET in changing initial management plans in patients with untreated head and neck cancer. Secondary aims were to determine the incremental staging information provided by PET and to documen
Publikováno v:
Clinical Nuclear Medicine. 29:81-85
Purpose: Strontium-89 (Sr-89) chloride is an effective palliative treatment of the bone metastases of prostate cancer. Chemotherapy has also been shown to have a palliative benefit in this disease. We aimed to determine the benefits and complications
Autor:
Brian Le, Katie Doan, Jennifer Philip, Dishan H. Gunawardana, Di Saward, Matthew Conron, Odette Spruyt, Jaclyn Yoong, Linda Mileshkin
Publikováno v:
Journal of palliative medicine. 17(5)
Lung cancer remains the leading cause of cancer death, and it is known many affected will have significant palliative care needs. Evidence suggests that early involvement of palliative care can translate into improvements in quality of care, quality
Autor:
Jayne Ramshaw, Dishan H. Gunawardana, Andrew M. Scott, Michael J. Fulham, Amanda J. Byrne, Ben Kelley, John Stuckey
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 49(9)
The aims of our study were to examine the impact of PET in changing management in patients with proven or suspected colorectal cancer recurrence and to assess the impact of management change on disease-free survival. Methods: Symptomatic patients wit
Publikováno v:
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 15(12)
MRI is routinely performed to detect recurrence in patients with primary brain tumors, but it may not differentiate recurrent tumor from radiation-induced necrosis reliably. Thallium-201 single-photon emission computed tomography (201Tl-SPECT) might
Autor:
Fiona O, Roberts, Dishan H, Gunawardana, Kunthi, Pathmaraj, Anthony, Wallace, Paul L, U, Tian, Mi, Sam U, Berlangieri, Graeme J, O'Keefe, Chris C, Rowe, Andrew M, Scott
Publikováno v:
Journal of nuclear medicine technology. 33(1)
The use of PET in Australia has grown rapidly. We conducted a prospective study of the radiation exposure of technologists working in PET and evaluated the occupational radiation dose after implementation of strategies to lower exposure.Radiation dos
Autor:
Dishan H, Gunawardana, Russell L, Basser, Ian D, Davis, Jonathan, Cebon, Paul, Mitchell, Craig, Underhill, Trevor J, Kilpatrick, Katrina, Reardon, Michael D, Green, Peter, Bardy, Pene, Amor, David, Crump, Siobhan, Ng, Roger L, Nation, C Glenn, Begley
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research. 9(6)
Leukemia inhibitory factor (LIF) is a pleiotropic molecule of the interleukin 6 family of cytokines. We aimed to examine the safety, pharmacokinetics, and biological effects of recombinant human LIF (rhLIF, emfilermin) in patients with advanced cance